Disclosed is a pharmaceutical composition comprising a stable polyallylamine hydrochloride polymer in which between about 4% to about 12% by weight of the polymer is a chloride anion and a pharmaceutically acceptable carrier or diluent.

 
Web www.patentalert.com

< Genetic polymorphisms associated with coronary events and drug response, methods of detection and uses thereof

> Polynucleotides encoding C-type lectin polypeptides and methods of use thereof

> Use of an epitope of vascular endothelial growth factor receptor KDR/Flk-1
~ 00523